Analysts’ updated eps estimates for Friday, November 28th:
Desjardins began coverage on shares of Alamos Gold (NYSE:AGI) (TSE:AGI). They issued a buy rating on the stock.
Anheuser-Busch InBev SA/NV (NYSE:BUD) had its buy rating reissued by analysts at The Goldman Sachs Group, Inc..
CollPlant Biotechnologies (NASDAQ:CLGN) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $12.00 price target on the stock.
CNH Industrial (NYSE:CNH) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating. JPMorgan Chase & Co. currently has $10.00 target price on the stock.
Canadian National Railway (NYSE:CNI) (TSE:CNR) was upgraded by analysts at CIBC from a neutral rating to an outperformer rating. CIBC currently has $151.00 price target on the stock, up from their previous price target of $146.00.
Deutsche Boerse (OTCMKTS:DBOEY) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.
easyJet (OTCMKTS:ESYJY) was upgraded by analysts at Sanford C. Bernstein from a market perform rating to an outperform rating.
Heineken (OTCMKTS:HEINY) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating.
Desjardins initiated coverage on shares of Kinross Gold (NYSE:KGC) (TSE:K). Desjardins issued a buy rating on the stock.
Moncler (OTCMKTS:MONRY) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.
Nordic American Tankers (NYSE:NAT) had its hold rating reissued by analysts at Jefferies Financial Group Inc.. Jefferies Financial Group Inc. currently has a $3.50 target price on the stock.
Netflix (NASDAQ:NFLX) had its buy rating reiterated by analysts at Rosenblatt Securities. They currently have a $152.00 target price on the stock, down from their previous target price of $153.00.
Prada (OTCMKTS:PRDSY) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating.
Somnigroup International (NYSE:SGI) was upgraded by analysts at Wall Street Zen from a hold rating to a buy rating.
Travere Therapeutics (NASDAQ:TVTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $47.00 price target on the stock.
Receive News & Ratings for Alamos Gold Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alamos Gold Inc and related companies with MarketBeat.com's FREE daily email newsletter.
